Meta-analysisindependent cross-checkabstract only checked I-INTB-08 standard review

Arm swelling after breast-cancer lymph-node surgery

Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.

Overview

DiSipio T et al.. Lancet Oncol 2013 · PMID 23540561 · DOI 10.1016/S1470-2045(13)70076-7

About 1 in 5 survivors develop arm lymphoedema; risk is about four times higher after full axillary dissection.

Does the study support the specific claim? Partly · Methodological quality: moderate

Study explained simply

What did the researchers want to find out?: Estimate lymphoedema incidence
How was the study done?: Meta-analysis
How many people, animals or samples were studied?: 72 studies
What was actually found?: 16.6% overall; 19.9% after dissection vs 5.6% after sentinel biopsy
How large was the observed effect?: about 4-fold
What do the results mean in everyday life?: Removing many lymph nodes often causes lasting arm swelling.
What are the study's limitations?: Heterogeneous studies; abstract only
What does it say about Elawady's specific claim?: Supports his concern about lymph-node removal as a harm.
Do the results apply to Germany and Europe?: High
What can explicitly not be concluded from this study?: Cannot conclude that lymph-node surgery never benefits patients.

Authors: DiSipio T et al.
Journal: Lancet Oncol
Year: 2013
Identifier: PMID 23540561 DOI 10.1016/S1470-2045(13)70076-7
Verification: verified – PubMed efetch 2026-10-25
Retracted: no
Corrections: none
Extent checked: abstract only
Conflicts of interest and funding: Funding: National Breast Cancer Foundation, Australia (abstract)

How common is arm lymphoedema after breast cancer, and what are the risk factors?

Study design: Meta-analysis – Systematic review and random-effects meta-analysis
Population: Breast-cancer survivors
Country: Multinational
Period: studies 2000-2012
Sample size: 72 studies (incidence); 29 (risk factors)
Inclusion and exclusion criteria: Studies assessing incidence/prevalence or risk factors of arm lymphoedema

Exposure / intervention: Breast-cancer treatment, extent of axillary surgery
Comparator: Sentinel-node biopsy vs axillary dissection
Endpoints: Arm lymphoedema incidence
Statistical methods: Random-effects pooling, exact binomial CIs

Results: Pooled incidence 16.6% (95% CI 13.6-20.2); 21.4% (14.9-29.8) in prospective cohorts. About four times higher after axillary lymph-node dissection (19.9%, 13.5-28.2) than after sentinel-node biopsy (5.6%, 6.1-7.9 as reported). Strong-evidence risk factors: extensive surgery (axillary dissection, more nodes removed, mastectomy) and overweight/obesity.
Absolute risks: About one in five survivors develop arm lymphoedema
Authors' conclusion: More than one in five women who survive breast cancer will develop arm lymphoedema.

Precise pooled estimate; the CI reported for sentinel-node biopsy appears inconsistent in the abstract and is quoted as published.

Documents a real harm of extensive lymph-node removal, which is part of why oncology moved to sentinel-node biopsy.

Harm must be weighed against staging and regional-control benefits.

High.

Solid evidence that axillary dissection carries a substantial lymphoedema burden.

Multidimensional assessment
Multidimensional assessment
Authenticity of the source	verified
Methodological quality	moderate
Risk of bias	some concerns
Precision of results	moderate
Directness	direct
Reproducibility	replicated
Consistency with the overall evidence	consistent
Regional transferability	high
Adequacy of the interpretation (by the archive)	not applicable

Prevention strategies.